Publication | Closed Access

EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA1c levels in db/db mice and prolongs the survival of stroke-prone rats

Selective Sglt2 InhibitorMedicineDiabetesPharmacologyCell DeathVascular BiologyNeuroprotectionNeurologyBlood GlucoseCerebral Blood FlowReperfusion InjuryStrokeCell BiologyDb/db MiceIschemic SyndromeCerebral Vascular Regulation